YESAFILI

Prezentare produs

About YESAFILI

YESAFILI is a prescription medicine formulated for ophthalmic use. It is classified as a vascular endothelial growth factor inhibitor designed to address specific retinal conditions. This medication is administered by a qualified healthcare professional through an intravitreal injection directly into the eye. Patients should consult with their ophthalmologist to determine if this treatment is appropriate for their specific clinical diagnosis and medical history. The administration process must be conducted under sterile conditions in a clinical setting to ensure patient safety and therapeutic efficacy.

Key Benefits & Uses

• Used for the treatment of neovascular age-related macular degeneration.
• Indicated for visual impairment due to macular edema secondary to retinal vein occlusion.
• Prescribed for the management of diabetic macular edema to help maintain or improve visual acuity.

Active Ingredient & Action

The active ingredient in YESAFILI is aflibercept. This substance acts as a fusion protein that binds to vascular endothelial growth factor-A and placental growth factor. By inhibiting these factors, the medication helps to reduce abnormal blood vessel growth and vascular permeability within the retina, which are primary drivers of fluid leakage and vision loss in the targeted conditions.

Important Notes

YESAFILI is intended for professional use only. Patients must report any symptoms of eye pain, redness, or sudden vision changes to their doctor immediately following administration. Always follow the specific treatment schedule provided by your medical specialist.